-
Dr. Yishan Ye: Advancing Haploidentical Transplantation — Toward “Timely Access to Optimal Donors for All” | ICIC 2025
To promote innovation in China’s cell therapy and immunotherapy fields, advance discussion of key scientific challenges, share the latest clinical research, and strengthen global collaboration and translational progress, the 2025…
-
Prof. Tak W. Mak: The Multifaceted Challenges and Collaborative Innovation in TCR Clinical Translation—From Target Selection to Combination Strategies | CTI 2025
To advance innovation in China’s cell and immunotherapy landscape, deepen exchanges on key scientific questions, and share the latest clinical research progress, the 2025 International Cell and Immunotherapy Conference (CTI 2025)—jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Zhejiang Society of Immunology, and the Zhejiang Anti-Cancer Association, and co-hosted by…
-
EBMT President-Elect Prof. Ibrahim Yakoub-Agha: A New Dimension in MDS Management — Genomics, Transplant Timing, and Future Directions | ICCI 2025
To promote innovation in China’s cell and immunotherapy fields, facilitate in-depth exchange on key scientific issues, share the latest clinical research progress, and advance global collaboration and clinical translation, the…
Connecting Medical Expertise through Media
